Results 81 to 90 of about 4,405,871 (302)

Strain and Shear Wave Elastography in Thyroid Nodules: Tissue Stiffness as a Complementary Risk Marker for Differentiating Benign, Indeterminate, and Malignant Cytology

open access: yesHead &Neck, EarlyView.
ABSTRACT Objective To evaluate the diagnostic performance of shear wave elastography (SWE) and strain elastography (SE) as complementary techniques to conventional B‐mode ultrasound for differentiating benign, indeterminate, and malignant thyroid nodules. Methods This prospective cross‐sectional study included 208 thyroid nodules evaluated using B‐mode
Kairo Alexandre Alves Silveira   +5 more
wiley   +1 more source

Pericardial Effusion in Primary Hypothyroidism

open access: yesپزشکی بالینی ابن سینا, 2000
The incidence  of pericardial  effusion  in untreated   hypothyroidism  is    reported to be 30%  to  80%.  The   study   of  pericardial effusion in primary    hypothyroidism  was our objective.
Mostafa Ansari
doaj  

Out-of-Reference Range Thyroid-Stimulating Hormone Levels in Levothyroxine-Treated Primary Hypothyroid Patients: A Multicenter Observational Study

open access: yesFrontiers in Endocrinology, 2017
ObjectiveAlthough levothyroxine (LT4) replacement therapy for hypothyroidism has been established as safe, inexpensive and effective, many studies from different countries reported out-of-reference range thyroid-stimulating hormone (TSH) values for the ...
Dilek Gogas Yavuz   +13 more
doaj   +1 more source

Pituitary hyperplasia secondary to primary hypothyroidism

open access: yesClinical Case Reports, 2020
Severe primary hypothyroidism should be considered in the differential diagnosis of pituitary enlargement. Thyroid hormone replacement therapy should lead to regression of pituitary hyperplasia.
Beatriz Martinez Quintero   +1 more
doaj   +1 more source

Association between hypothyroidism and metabolic dysfunction-associated steatohepatitis in adults with obesity without diabetes

open access: yes
Background: Metabolic dysfunction-associated steatohepatitis (MASH), often linked with obesity-related fat deposition, is increasingly prevalent as global obesity rates rise. Data from Latin America, and particularly Peru, remain limited.
Yang, Wah   +6 more
core   +1 more source

Combined atypical primary hypoadrenocorticism and primary hypothyroidism in a dog [PDF]

open access: yes, 2016
A dog with combined atypical primary hypoadrenocorticism and primary hypothyroidism is described. The dog presented with waxing and waning, vague complaints since more than a year and had been treated with several drugs without complete resolution of ...
Smets, Pascale   +5 more
core  

Circadian changes in pulsatile TSH release in primary hypothyroidism

open access: yes, 1992
We evaluated pulsatile and circadian TSH secretion in primary hypothyroidism. In a prospective study, blood was sampled every 10 minutes during 24 hours for assay of TSH (IRMA). Thyroid hormones and TSH responsiveness to TRH were then measured.
Prank, K.   +4 more
core   +1 more source

Development and Preliminary Validation of a Modified Thyroid Symptom Questionnaire (TSQ)

open access: yesHead &Neck, EarlyView.
ABSTRACT Background This study aimed to modify and validate the Thyroidectomy Voice and Symptom Questionnaire (TVSQ) to serve as a symptom screening tool in benign thyroid disease. Methods A 32‐item modified TVSQ was developed and administered alongside a symptom checklist to outpatients; controls were recruited to determine discriminative validity ...
Vikash Yogaraj   +2 more
wiley   +1 more source

Lipid Abnormalities in Hypothyroidism

open access: yes, 2019
In order to understand the relation between lipid abnormalities and hypothyroidism its essential to have a complete understanding of lipid metabolism and the thyroid gland and its metabolism too, only then a clinician can diagnose hypothyroidism that is ...
Bhatti, Hassan Nawaz
core  

Tolerability of Adjuvant Nivolumab in Esophageal or Gastroesophageal Junction Cancer: A Real‐World Study

open access: yesInternational Journal of Cancer, EarlyView.
ABSTRACT Adjuvant nivolumab is approved for esophageal or gastroesophageal junction cancer after neoadjuvant chemoradiotherapy and resection. In the CheckMate‐577 trial, Grade 3–5 nivolumab‐related adverse events (AEs) occurred in 5% of patients, with early discontinuation due to toxicity in 9%. However, real‐world data on immunotherapy‐related adverse
Michelle Koops van ’t Jagt   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy